Targeting the SUMO pathway as a novel treatment for anaplastic thyroid cancer.
De Andrade JP, Lorenzen AW, Wu VT, Bogachek MV, Park JM, Gu VW, Sevenich CM, Cassady VC, Beck AC, Kulak MV, Robinson RA, Lal G, Weigel RJ.
De Andrade JP, et al. Among authors: robinson ra.
Oncotarget. 2017 Oct 23;8(70):114801-114815. doi: 10.18632/oncotarget.21954. eCollection 2017 Dec 29.
Oncotarget. 2017.
PMID: 29383121
Free PMC article.